Business Context and Reporting Period
This Form 6-K filing by JIADE Ltd covers the month of March 2026, specifically dated March 20, 2026. The report details a change in the composition of the Board of Directors, involving the resignation of an existing director and the appointment of a new independent director.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of corporate governance changes and contains no financial performance data.
Material Changes
- Resignation: Dr. Shaoping Lu resigned as a director, member of the audit, nominating and corporate governance, and compensation committees, and chairperson of the nominating and corporate governance committee, effective March 19, 2026.
- Reason for Departure: Dr. Lu cited personal reasons and confirmed no disagreement with the Company regarding operations, policies, or practices.
- Appointment: On March 20, 2026, the Board appointed Dr. Yi Chen as an independent director.
- New Roles: Dr. Chen was appointed to the nominating and corporate governance, audit, and compensation committees, and named chairperson of the nominating and corporate governance committee.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future business performance. No specific risks or contingencies related to financial operations were disclosed. The appointment of Dr. Chen was confirmed to satisfy Nasdaq independence requirements and qualify as an audit committee financial expert under SEC rules.
Key Facts for Investor Verification
- Verify the independence status and background of the newly appointed director, Dr. Yi Chen, particularly her qualifications as an audit committee financial expert.
- Confirm that the resignation of Dr. Shaoping Lu was indeed due to personal reasons and not indicative of undisclosed governance disputes.
- Check subsequent filings (e.g., Form 20-F) for the next available financial data, as this 6-K contains no financial metrics.
- Review the updated Board composition to ensure compliance with Nasdaq listing rules regarding committee membership.